Anna Latiano
Overview
Explore the profile of Anna Latiano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
8086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cannarozzi A, Biscaglia G, Parente P, Latiano T, Gentile A, Ciardiello D, et al.
Crit Rev Oncol Hematol
. 2025 Mar;
:104694.
PMID: 40064251
Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide. Despite advances in screening and treatment, CRC is heterogeneous and the response to therapy varies significantly,...
2.
Tavano F, Napoli A, Gioffreda D, Palmieri O, Latiano T, Tardio M, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005817
Pancreatic ductal adenocarcinoma (PDAC) is associated with intratumoral microbiota changes. However, defining the normal pancreatic microbial composition remains a challenge. Herein, we tested the hypothesis that the microbial profiling of...
3.
Fernandes M, Palmieri O, Castellana S, Spanetta M, Latiano T, Lupo C, et al.
Brain Res Bull
. 2025 Feb;
222:111251.
PMID: 39938754
Introduction: Obstructive sleep apnoea syndrome (OSAS) is considered a risk factor for several comorbidities. Alteration in gut microbiome was documented in OSAS animal models and in paediatric patients. This study...
4.
Cannarozzi A, Massimino L, Latiano A, Parigi T, Giuliani F, Bossa F, et al.
Comput Struct Biotechnol J
. 2024 Sep;
23:3407-3417.
PMID: 39345902
Inflammatory bowel diseases (IBD) are classified into two entities, namely Crohn's disease (CD) and ulcerative colitis (UC), which differ in disease trajectories, genetics, epidemiological, clinical, endoscopic, and histopathological aspects. As...
5.
Brina A, Palmieri O, Cannarozzi A, Tavano F, Guerra M, Bossa F, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337632
Achalasia is a rare and complex esophageal disease of unknown etiology characterized by difficulty in swallowing due to the lack of opening of the lower esophageal sphincter and the absence...
6.
Galvez-Montosa F, Peduzzi G, Sanchez-Maldonado J, Ter Horst R, Cabrera-Serrano A, Gentiluomo M, et al.
Int J Cancer
. 2024 Sep;
156(2):339-352.
PMID: 39319538
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with patients having unresectable or metastatic disease at diagnosis, with poor prognosis and very short survival. Given that genetic...
7.
Cannarozzi A, Latiano A, Massimino L, Bossa F, Giuliani F, Riva M, et al.
United European Gastroenterol J
. 2024 Aug;
12(10):1461-1480.
PMID: 39215755
Various extrinsic and intrinsic factors such as drug exposures, antibiotic treatments, smoking, lifestyle, genetics, immune responses, and the gut microbiome characterize ulcerative colitis and Crohn's disease, collectively called inflammatory bowel...
8.
Tavano F, Latiano A, Palmieri O, Gioffreda D, Latiano T, Gentile A, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39126005
Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid...
9.
Palmieri O, Bossa F, Castellana S, Latiano T, Carparelli S, Martino G, et al.
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065032
Growing evidence suggests that alterations in the gut microbiome impact the development of inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC). Although IBD often requires the...
10.
Piccardi M, Gentiluomo M, Bertoncini S, Pezzilli R, Eross B, Bunduc S, et al.
Biol Res
. 2023 Aug;
56(1):46.
PMID: 37574541
Background: The genomes of present-day non-Africans are composed of 1-3% of Neandertal-derived DNA as a consequence of admixture events between Neandertals and anatomically modern humans about 50-60 thousand years ago....